Immunome (IMNM) Net Cash Flow (2019 - 2026)
Immunome (IMNM) posted Net Cash Flow of -$70.8 million for Q1 2026, down 118.59% on a QoQ basis from $380.8 million in Q4 2025, and down 161.95% year-over-year from $114.3 million in Q1 2025.
Immunome (IMNM) Net Cash Flow (2019 - 2026) Analysis & Trends
Immunome's Net Cash Flow history runs 8 years deep, the most recent figure standing at -$70.8 million for Q1 2026.
- Quarterly Net Cash Flow fell 161.95% year-over-year to -$70.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $325.2 million (up 2785.3% YoY) and the FY2025 annual result came in at $510.2 million, up 1042.19% from the prior year.
- Net Cash Flow was -$70.8 million for Q1 2026 at Immunome, down from $380.8 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $380.8 million in Q4 2025 and bottomed at -$113.6 million in Q2 2025.
- A 5-year average of $31.4 million and a median of -$6.4 million in 2022 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2024 — Net Cash Flow sank 1637.53% — and 2025, when it soared 3217.32%.
- Immunome's Net Cash Flow stood at -$6.8 million in 2022, then surged by 218.99% to $8.0 million in 2023, then sank by 251.99% to -$12.2 million in 2024, then surged by 3217.32% to $380.8 million in 2025, then tumbled by 118.59% to -$70.8 million in 2026.
- Business Quant data shows IMNM's Net Cash Flow at -$70.8 million in Q1 2026, $380.8 million in Q4 2025, and $128.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 10.56 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 224.46 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 457.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -152.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Immunome | 2.49 Bn | 1.91 Bn | - | -70.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -70.79 Mn |
| Mar 31, 2026 | -70.79 Mn |
| Dec 31, 2025 | 380.84 Mn |
| Dec 31, 2025 | 380.84 Mn |
| Sep 30, 2025 | 128.76 Mn |
| Sep 30, 2025 | 128.76 Mn |
| Jun 30, 2025 | -113.63 Mn |
| Jun 30, 2025 | -113.63 Mn |
| Mar 31, 2025 | 114.26 Mn |
| Mar 31, 2025 | 114.26 Mn |
| Dec 31, 2024 | -12.22 Mn |
| Dec 31, 2024 | -12.22 Mn |
| Sep 30, 2024 | -9.76 Mn |
| Sep 30, 2024 | -9.76 Mn |
| Jun 30, 2024 | -104.39 Mn |
| Jun 30, 2024 | -104.39 Mn |
| Mar 31, 2024 | 171.04 Mn |
| Mar 31, 2024 | 171.04 Mn |
| Dec 31, 2023 | 8.04 Mn |
| Dec 31, 2023 | 8.04 Mn |